Navigation Links
Brainlab Continues to Advance Global Treatment Access and Consistency in Cancer Care Centers
Date:7/25/2012

MUNICH, July 25, 2012 /PRNewswire/ -- Today Brainlab announced the inauguration of the 300th Novalis® Radiosurgery Program. The addition of another healthcare facility to the worldwide Novalis treatment, communication and collaboration network allows Brainlab to expand and build upon this distinctive and comprehensive program that the company established 15 years ago and continues to transform. These centers all share premium, standard-defining Brainlab technology, allowing for direct and consistent implementation of the same treatment protocols for radiosurgery and stereotactic body radiation therapy (SBRT).

The 300th Novalis Radiosurgery Program represents a significant milestone since Brainlab inaugurated the first Novalis Radiosurgery system at the University of California, Los Angeles (UCLA), USA. Radiosurgery has advanced significantly over the past 15 years, with much of the conversation focusing around hardware innovations. While these iterations are an important part of industry progress, changing the paradigm has been realized by advances in software and patient positioning, such as volumetric dose planning, conformal dynamic arcs and 6D patient alignment.

The Novalis Radiosurgery Program has remained a constant within the industry progression, offering a comprehensive approach that encompasses technology, best practice and leadership. Facilities can be confident that they are consistently delivering a high standard of radiosurgery and SBRT, delivered via a premium configuration of components. All 300 Novalis Radiosurgery Program facilities can share protocols without extensive hardware adaptation to their Novalis-configured linear accelerator. This uniformity has the capacity to liberate customers, allowing them to adapt and drive new treatment protocols in high quality, non-invasive1 cancer treatment.

"The Novalis Radiosurgery Program has opened doors for patients in
'/>"/>

SOURCE Brainlab
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
2. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
3. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
4. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
5. TeraDiscoveries to Use its Inverse Design Software Running on Windows Azure to Advance Its Computational Drug Discovery Process
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry
8. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
9. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
10. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
11. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... DALLAS , August 29, 2014 ... Synthesis Market by Product & Services (Equipment, Reagent, ... Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, ... by MarketsandMarkets, the global Oligonucleotide Synthesis Market is ... $1,070.7 Million in 2014, growing at a CAGR ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Multiple Sclerosis Drugs Market 2014-2018" report ... a chronic, inflammatory medical condition that results in demyelination, ... because of an abnormal response by the immune system, ... It is a potentially debilitating disease in which the ...
(Date:8/29/2014)... British Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the ... fiscal year-end financial statements.  The Company recently changed its ... facilitate an application to list its common stock on ... DelMar,s financial statements as filed with the ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... SHANGHAI , Aug. 3 /PRNewswire-Asia/ -- Sangon ... company, and Bio Basic Inc. (BBI), a Toronto ... completion of,a $10 million round of funding ... scale research & development, marketing and sales of its ...
... Aug. 3 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services,Holdings Limited ... of the largest,network of radiotherapy and diagnostic imaging centers in ... for the second,quarter ended June 30, 2010 , before ... Medical,s management will hold an earnings conference call at ...
Cached Medicine Technology:Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures 2Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures 3Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010 2Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010 3
(Date:8/30/2014)... By Randy Dotinga ... -- About one in five patients operated on for broken ... after surgery, a new study finds. Less-educated patients ... times more likely to be "doctor shoppers," said study lead ... Lexington, Ky. Overall, he said, the study suggests that doctors ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Hastings and ... injury attorneys located throughout Arizona is pleased to report ... is one specific example among many cases where Hastings ... are able to retain a greater portion of their ... case that providing a positive solution for Arizona car ...
(Date:8/30/2014)... medication commonly used to treat gout, before and ... potential complications from this type of surgery, but ... effects, according to a study published by ... online to coincide with its presentation at the ... after cardiac surgery include postpericardiotomy syndrome (the occurrence ...
(Date:8/30/2014)... "My niece developed a nighttime fever, and I ... fever might get worse," said an inventor from Montgomery, ... how she was doing, I developed this monitoring system." ... a child's temperature. The unit instantly alerts parents if ... medical care can be given, which is designed to ...
(Date:8/30/2014)... 2014 Bringing forth the great opportunities, ... announces the Labor Day discount on all SEO services. ... the complete services related to internet marketing. Their dedicated ... and others do have a deep understanding for their ... their work and since the inception, they have worked ...
Breaking Medicine News(10 mins):Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Profit By Search Announces Labor Day Discount on SEO Services 2
... announced its approval for the use of DDT indoors, as ... pesticide, was banned// after it was found to be harmful ... Arata Kochi, director of the World Health Organization (WHO) malaria ... is indoor residual house spraying. Of the dozen pesticides WHO ...
... Studies presented at the 42nd Annual Meeting of the ... revealed that ACTOS? (pioglitazone HCl), an oral// antidiabetic medication, ... of heart attack and/or C and acute coronary syndrome ... disease (CVD) is the leading cause of premature death ...
... Researchers working closely with African American inner city ... problematic social incidents to help measure// which children ... ,"The girls preferred the cartoons over ... study leader Stephen S. Leff, Ph.D., a pediatric ...
... Hopkins has found that in addition to previously known ... of anemia in older adults, there// also exists ... ,"Our work supports the notion that mild anemia ... impairment in older adults," says Paulo Chaves, M.D., P.h.D., ...
... treatment for malaria has been developed with the help of ... in Africa. A system based on fluid// replacement for children ... in London in collaboration with the Wellcome Trust Kenya Medical ... of millions of kids, who die every year due to ...
... 1199NW has said that it supports the "Marty Smith" ... a partner when// they visit high-risk patients. Marty Smith ... of Larry Clark, a child rapist whose mother had ... his medications. ,Smith's case proves that mental ...
Cached Medicine News:Health News:ACTOS Linked to Several Cardiovascular Benefits 2Health News:ACTOS Linked to Several Cardiovascular Benefits 3Health News:ACTOS Linked to Several Cardiovascular Benefits 4Health News:Cartoons to Indicate Aggressiveness in Urban School Girls 2Health News:Cartoons to Indicate Aggressiveness in Urban School Girls 3Health News:Anemia Affects Both Body and Mind 2Health News:A Novel approach in Malaria treatment 2
... a hot air drying device for polyacrylamide and ... cellophane support for easy viewing. The assembly table ... surface for the drying frame. The dryer holds ... 115 V, 60 Hz system includes a gel ...
... The PRO6000 power supply ... Thermo's power supply product offering. ... proteomic and genomic electrophoresis. This ... to proteomic applications such as ...
The 570-90 is capable of producing up to 500 volts or 2,500 milliamps. It is an excellent choice for running all types of electroblotting applications. Also ideal for PAGE, SDS-PAGE, and DNA or RNA s...
... techniques such as submarine electrophoresis and SDS-PAGE, ... the Series 90 Programmable Power Supplies will ... Programmable Power Supplies are available in four ... All models operate in constant voltage, current ...
Medicine Products: